Trial intelligence / Profile preview

Buspirone challenge test in dyspepsia during fMRI

NL-OMON20895Suspended

Start
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of buspirone in functional dyspepsia (FD) (2 arms). Primary endpoints: Hormonal response during buspirone challenge, Dyspeptic symptom scores during test and 1 more. Started Jun 2005; status: suspended.

02

Drugs

buspirone
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on NL-OMON20895.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20895.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call